PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…
Wednesday 25 June, 2025 As Wimbledon 2025 prepares to serve up another season of drama, tradition, and excellence, Spencer Dryer,…
SINGAPORE, June 11, 2025 /PRNewswire/ -- On June 3rd 2025, DFINITY Foundation hosted a market-leading selection of international technologists, developers, policy…
San Francisco, CA, June 04, 2025 (GLOBE NEWSWIRE) -- For many skilled professionals hoping to live and work in the…